Literature DB >> 24105821

Advanced multiplicity adjustment methods in clinical trials.

Mohamed Alosh1, Frank Bretz, Mohammad Huque.   

Abstract

During the last decade, many novel approaches for addressing multiplicity problems arising in clinical trials have been introduced in the literature. These approaches provide great flexibility in addressing given clinical trial objectives and yet maintain strong control of the familywise error rate. In this tutorial article, we review multiple testing strategies that are related to the following: (a) recycling local significance levels to test hierarchically ordered hypotheses; (b) adapting the significance level for testing a hypothesis to the findings of testing previous hypotheses within a given test sequence, also in view of certain consistency requirements; (c) grouping hypotheses into hierarchical families of hypotheses along with recycling the significance level between those families; and (d) graphical methods that permit repeated recycling of the significance level. These four different methodologies are related to each other, and we point out some connections as we describe and illustrate them. By contrasting the main features of these approaches, our objective is to help practicing statisticians to select an appropriate method for their applications. In this regard, we discuss how to apply some of these strategies to clinical trial settings and provide algorithms to calculate critical values and adjusted p-values for their use in practice. The methods are illustrated with several numerical examples.
Copyright © 2013 John Wiley & Sons, Ltd.

Keywords:  adaptive alpha; gatekeeping; graphical methods; multiple testing; α-propagation

Mesh:

Year:  2013        PMID: 24105821     DOI: 10.1002/sim.5974

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  15 in total

1.  Large sample inference for a win ratio analysis of a composite outcome based on prioritized components.

Authors:  Ionut Bebu; John M Lachin
Journal:  Biostatistics       Date:  2015-09-08       Impact factor: 5.899

Review 2.  Design, data monitoring, and analysis of clinical trials with co-primary endpoints: A review.

Authors:  Toshimitsu Hamasaki; Scott R Evans; Koko Asakura
Journal:  J Biopharm Stat       Date:  2017-10-30       Impact factor: 1.051

Review 3.  Outcomes following the treatment of bicondylar tibial plateau fractures with fine wire circular frame external fixation compared to open reduction and internal fixation: A systematic review.

Authors:  Tarek Boutefnouchet; Ayaz S Lakdawala; Panayiotis Makrides
Journal:  J Orthop       Date:  2015-02-24

Review 4.  Establishing an evaluation mode with multiple primary outcomes based on combination of diseases and symptoms in TCM clinical trials.

Authors:  Jing Hu; Shuo Liu; Weihong Liu; Huina Zhang; Jing Chen; Hongcai Shang
Journal:  Ann Transl Med       Date:  2017-11

5.  Change point detection for clustered expression data.

Authors:  Miriam Sieg; Lina Katrin Sciesielski; Karin Michaela Kirschner; Jochen Kruppa
Journal:  BMC Genomics       Date:  2022-07-06       Impact factor: 4.547

6.  Assessment of improvement in anxiety severity for children with autism spectrum disorder: The matched correspondence analysis approach.

Authors:  Se-Kang Kim; Dean McKay; Sandra L Cepeda; Sophie C Schneider; Jeffrey Wood; Eric A Storch
Journal:  J Psychiatr Res       Date:  2021-12-15       Impact factor: 5.250

7.  Sequential, Multiple-Assignment, Randomized Trials for COMparing Personalized Antibiotic StrategieS (SMART-COMPASS).

Authors:  Scott R Evans; Dean Follmann; Ying Liu; Thomas Holland; Sarah B Doernberg; Nadine Rouphael; Toshimitsu Hamasaki; Yunyun Jiang; Judith J Lok; Thuy Tien T Tran; Anthony D Harris; Vance G Fowler; Helen Boucher; Barry N Kreiswirth; Robert A Bonomo; David Van Duin; David L Paterson; Henry Chambers
Journal:  Clin Infect Dis       Date:  2019-05-17       Impact factor: 9.079

8.  Application of the Wei-Lachin multivariate one-directional test to multiple event-time outcomes.

Authors:  John M Lachin; Ionut Bebu
Journal:  Clin Trials       Date:  2015-09-02       Impact factor: 2.486

9.  Unbiased estimation in seamless phase II/III trials with unequal treatment effect variances and hypothesis-driven selection rules.

Authors:  David S Robertson; A Toby Prevost; Jack Bowden
Journal:  Stat Med       Date:  2016-04-21       Impact factor: 2.373

10.  Many-to-one comparisons after safety selection in multi-arm clinical trials.

Authors:  Gerald Hlavin; Lisa V Hampson; Franz Koenig
Journal:  PLoS One       Date:  2017-06-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.